Oxlumo®
OXLUMO® is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
![](https://vivoinfusion.com/wp-content/uploads/2024/02/oxlumo-lumasiran-logo.png)
MANUFACTURER: Alnylam Pharmaceuticals, Inc. |
CLASS: Gene Therapy |
WHAT IT TREATS: Primary Hyperoxaluria Type 1 |
PRESCRIBED BY: Nephrologists
|
HOW ADMINISTERED: Subcutaneous Injection |
FREQUENCY: Monthly |
Length of infusion: N/A |
FOR MORE INFORMATION: |